CD37 and non-Hodgkin lymphoma: Interestingly, a CD37 antibody radiolabeled with lutetium-177 ([177Lu]betalutin) is currently under clinical evaluation (NCT01796171) for the management of patient with relapsed CD37+ non-Hodgkin lymphomas [27].